世界の結核診断＆治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tuberculosis Diagnostics and Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3705
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、123ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：産業装置

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、結核診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（皮膚検査、研究室検査）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・結核診断＆治療の市場動向
・企業の競争状況、市場シェア
・結核診断＆治療の種類別市場規模と予測2016-2027（皮膚検査、研究室検査）
・結核診断＆治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・結核診断＆治療の北米市場規模2016-2027（アメリカ、カナダ）
・結核診断＆治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・結核診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・結核診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・結核診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Cepheid Inc、Becton Dickinson、Hain LifeSciences、Abbott Laboratories、Alere, Inc、Roche AG、Hologic Corporation、bioMerieux、Sanofi、QIAGEN、Akonni Biosystems, Inc.、Epistem Holdings Plc、Gen-Probe Inc.、EIKEN Chemical、Thermo Fisher Scientific, Inc）
・結論

Market Analysis and Insights: Global Tuberculosis Diagnostics and Treatment Market
The global Tuberculosis Diagnostics and Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Diagnostics and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Diagnostics and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Diagnostics and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Diagnostics and Treatment market.

Global Tuberculosis Diagnostics and Treatment Scope and Market Size
Tuberculosis Diagnostics and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Diagnostics and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Skin Testing
Laboratory Testing

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cepheid Inc
Becton Dickinson
Hain LifeSciences
Abbott Laboratories
Alere, Inc
Roche AG
Hologic Corporation
bioMerieux
Sanofi
QIAGEN
Akonni Biosystems, Inc.
Epistem Holdings Plc
Gen-Probe Inc.
EIKEN Chemical
Thermo Fisher Scientific, Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Skin Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2016-2027)
2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions
2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Tuberculosis Diagnostics and Treatment Industry Dynamic
2.3.1 Tuberculosis Diagnostics and Treatment Market Trends
2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers
2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges
2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2016-2021)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue
3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2020
3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type
4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027)

5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application
5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
6.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type
6.2.1 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
6.2.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
6.2.3 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application
6.3.1 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
6.3.2 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
6.3.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country
6.4.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
6.4.2 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type
7.2.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application
7.3.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country
7.4.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
9.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type
9.2.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application
9.3.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country
9.4.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Details
11.1.2 Cepheid Inc Business Overview
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction
11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.1.5 Cepheid Inc Recent Development
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Details
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction
11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.2.5 Becton Dickinson Recent Development
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Details
11.3.2 Hain LifeSciences Business Overview
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction
11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.3.5 Hain LifeSciences Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction
11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Alere, Inc
11.5.1 Alere, Inc Company Details
11.5.2 Alere, Inc Business Overview
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction
11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.5.5 Alere, Inc Recent Development
11.6 Roche AG
11.6.1 Roche AG Company Details
11.6.2 Roche AG Business Overview
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction
11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.6.5 Roche AG Recent Development
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Details
11.7.2 Hologic Corporation Business Overview
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction
11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.7.5 Hologic Corporation Recent Development
11.8 bioMerieux
11.8.1 bioMerieux Company Details
11.8.2 bioMerieux Business Overview
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction
11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.8.5 bioMerieux Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction
11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.10.5 QIAGEN Recent Development
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Details
11.11.2 Akonni Biosystems, Inc. Business Overview
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction
11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.11.5 Akonni Biosystems, Inc. Recent Development
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Details
11.12.2 Epistem Holdings Plc Business Overview
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction
11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.12.5 Epistem Holdings Plc Recent Development
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Details
11.13.2 Gen-Probe Inc. Business Overview
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction
11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.13.5 Gen-Probe Inc. Recent Development
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Details
11.14.2 EIKEN Chemical Business Overview
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction
11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.14.5 EIKEN Chemical Recent Development
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Details
11.15.2 Thermo Fisher Scientific, Inc Business Overview
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction
11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021)
11.15.5 Thermo Fisher Scientific, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Skin Testing
Table 3. Key Players of Laboratory Testing
Table 4. Global Tuberculosis Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2016-2021)
Table 8. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027)
Table 10. Tuberculosis Diagnostics and Treatment Market Trends
Table 11. Tuberculosis Diagnostics and Treatment Market Drivers
Table 12. Tuberculosis Diagnostics and Treatment Market Challenges
Table 13. Tuberculosis Diagnostics and Treatment Market Restraints
Table 14. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tuberculosis Diagnostics and Treatment Market Share by Players (2016-2021)
Table 16. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020)
Table 17. Ranking of Global Top Tuberculosis Diagnostics and Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tuberculosis Diagnostics and Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service
Table 21. Date of Enter into Tuberculosis Diagnostics and Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tuberculosis Diagnostics and Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Cepheid Inc Company Details
Table 62. Cepheid Inc Business Overview
Table 63. Cepheid Inc Tuberculosis Diagnostics and Treatment Product
Table 64. Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 65. Cepheid Inc Recent Development
Table 66. Becton Dickinson Company Details
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Tuberculosis Diagnostics and Treatment Product
Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 70. Becton Dickinson Recent Development
Table 71. Hain LifeSciences Company Details
Table 72. Hain LifeSciences Business Overview
Table 73. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product
Table 74. Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 75. Hain LifeSciences Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product
Table 79. Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. Alere, Inc Company Details
Table 82. Alere, Inc Business Overview
Table 83. Alere, Inc Tuberculosis Diagnostics and Treatment Product
Table 84. Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 85. Alere, Inc Recent Development
Table 86. Roche AG Company Details
Table 87. Roche AG Business Overview
Table 88. Roche AG Tuberculosis Diagnostics and Treatment Product
Table 89. Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 90. Roche AG Recent Development
Table 91. Hologic Corporation Company Details
Table 92. Hologic Corporation Business Overview
Table 93. Hologic Corporation Tuberculosis Diagnostics and Treatment Product
Table 94. Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 95. Hologic Corporation Recent Development
Table 96. bioMerieux Company Details
Table 97. bioMerieux Business Overview
Table 98. bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 99. bioMerieux Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Tuberculosis Diagnostics and Treatment Product
Table 103. Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. QIAGEN Company Details
Table 106. QIAGEN Business Overview
Table 107. QIAGEN Tuberculosis Diagnostics and Treatment Product
Table 108. QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 109. QIAGEN Recent Development
Table 110. Akonni Biosystems, Inc. Company Details
Table 111. Akonni Biosystems, Inc. Business Overview
Table 112. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product
Table 113. Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 114. Akonni Biosystems, Inc. Recent Development
Table 115. Epistem Holdings Plc Company Details
Table 116. Epistem Holdings Plc Business Overview
Table 117. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product
Table 118. Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 119. Epistem Holdings Plc Recent Development
Table 120. Gen-Probe Inc. Company Details
Table 121. Gen-Probe Inc. Business Overview
Table 122. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product
Table 123. Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 124. Gen-Probe Inc. Recent Development
Table 125. EIKEN Chemical Company Details
Table 126. EIKEN Chemical Business Overview
Table 127. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product
Table 128. EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 129. EIKEN Chemical Recent Development
Table 130. Thermo Fisher Scientific, Inc Company Details
Table 131. Thermo Fisher Scientific, Inc Business Overview
Table 132. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product
Table 133. Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million)
Table 134. Thermo Fisher Scientific, Inc Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostics and Treatment Market Share by Type: 2020 VS 2027
Figure 2. Skin Testing Features
Figure 3. Laboratory Testing Features
Figure 4. Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Tuberculosis Diagnostics and Treatment Report Years Considered
Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tuberculosis Diagnostics and Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027)
Figure 13. Global Tuberculosis Diagnostics and Treatment Market Share by Players in 2020
Figure 14. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2020
Figure 16. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 20. North America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 21. North America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 22. United States Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 26. Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 27. Europe Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 28. Germany Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Region (2016-2027)
Figure 38. China Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Cepheid Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 58. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 59. Hain LifeSciences Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 61. Alere, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 62. Roche AG Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 63. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 64. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 66. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 67. Akonni Biosystems, Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 68. Epistem Holdings Plc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 69. Gen-Probe Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 70. EIKEN Chemical Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 71. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年）

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4987 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、結核（TB）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン（リファディン、リマクタン）、エタンブトール（ミアンブトール）、ピラジナミド）、用途別市場規模（活動性結核、潜...

世界の乳腺線維嚢胞診断＆治療市場規模・現状・予測（2021年-2027年）

Global Fibrocystic Breasts Diagnostics and Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4225 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、乳腺線維嚢胞診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診療所、診断センター、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のアレルギー診断＆治療市場規模・現状・予測（2021年-2027年）

Global Allergy Diagnostics And Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3779 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、アレルギー診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アッセイキット、消耗品、サービス）、用途別市場規模（食品アレルゲン、吸入アレルゲン、薬物アレルゲン、その他アレルゲン）、主要地域別市...

世界のドライアイ診断＆治療市場規模・現状・予測（2021年-2027年）

Global Dry Eye Disease Diagnostics and Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4161 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ドライアイ診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（蒸発性ドライアイ症候群、水性ドライアイ症候群）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメ...

世界のエクソソーム診断学＆治療市場規模・現状・予測（2021年-2027年）

Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3432 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、エクソソーム診断学＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬、ソフトウェア）、用途別市場規模（診断、治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の食物アレルギー診断＆治療市場規模・現状・予測（2021年-2027年）

Global Food Allergy Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4236 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、食物アレルギー診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断製品、機器、消耗品、サービス）、用途別市場規模（学術研究所、病院＆診療所、診断研究所）、主要地域別市場規模（北米、アメリカ、...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis(MPA) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4506 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、顕微鏡的多発血管炎（MPA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の骨髄性プロトポルフィリン症（EPP）治療市場規模・現状・予測（2021年-2027年）

Global Erythropoietic Protoporphyria (EPP) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4205 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、骨髄性プロトポルフィリン症（EPP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、補助療法、光線療法）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、オンライン薬局）、主要地...

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年） If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include: Isoniazid Rifampin (Rifadin, Rimactane) Etham…
世界の結核菌検査市場規模・現状・予測（2021年-2027年） Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs. Market Analysis and Insights: Global Mycobacterium Tuberculosis Testing Market The global Mycobacterium Tuberculosis Testing market size is projected to reach US$ XX million by 2027, from US$ XX …
結核ワクチン治療のグローバル市場2021 Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely use…
潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025 Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to sti…
潜在性結核感染（LTBI）検査のグローバル市場：規模・現状・予測2019-2025 Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to sti…